Effect of comorbidity on mortality in multiple sclerosis

Neurology

Volumn 85, Issue 3, 2015, Pages 240-247

  Marrie, Ruth Ann ^a   Elliott, Lawrence ^a   Marriott, James ^a   Cossoy, Michael ^a   Blanchard, James ^a   Leung, Stella ^a   Yu, Nancy ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b Manitoba Health   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; CHRONIC LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; EPILEPSY; FEMALE; FIBROMYALGIA; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MORTALITY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; SURVIVAL TIME; THYROID DISEASE; AGED; CANADA; COHORT ANALYSIS; EPIDEMIOLOGY; HEALTH SURVEY; MIDDLE AGED; PROCEDURES; TRENDS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; COMORBIDITY; FEMALE; HUMANS; MALE; MANITOBA; MIDDLE AGED; MORTALITY; MULTIPLE SCLEROSIS; POPULATION SURVEILLANCE;

EID: 84937719310     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001718     Document Type: Article

References (40)

1. Dean G. How many people in the world have multiple sclerosis? Neuroepidemiology 1994; 13: 1-7
2. Beck CA, Metz LM, Svenson LW, Patten SB. Regional variation of multiple sclerosis prevalence in Canada. Mult Scler 2005; 11: 516-519
3. Scalfari A, Knappertz V, Cutter G, Goodin DS, Ashton R, Ebers GC. Mortality in patients with multiple sclerosis. Neurology 2013; 81: 184-192
4. Bronnum-Hansen H, Koch-Henriksen N, Stenager E. Trends in survival and cause of death in Danish patients with multiple sclerosis. Brain 2004; 127: 844-850
5. Llorca J, Guerrero-Alonso P, Prieto-Salceda D. Mortality trends of multiple sclerosis in Spain, 1951-1997: an ageperiod-cohort analysis. Neuroepidemiology 2005; 24: 129-134
6. Ekestern E, Lebhert G. Mortality from multiple sclerosis in Austria 1970-2001: dynamics, trends, and prospects. Eur J Neurol 2004; 11: 511-520
7. Sadovnick AD, Ebers GC, Wilson RW, Paty DW. Life expectancy in patients attending multiple sclerosis clinics. Neurology 1992; 42: 991-994
8. Goodin DS, Corwin M, Kaufman D, et al. Causes of death among commercially insured multiple sclerosis patients in the United States. PLoS One 2014; 9: e105207
9. Lalmohamed A, Bazelier MT, Van Staa TP, et al. Causes of death in patients with multiple sclerosis and matched referent subjects: a population-based cohort study. Eur J Neurol 2012; 19: 1007-1014
10. Krokki O, Bloigu R, Ansakorpi H, Reunanen M, Remes AM. Neurological comorbidity and survival in multiple sclerosis. Mult Scler Relat Disord 2014; 3: 72-77
11. Health Information Management Branch. Population Report. Winnipeg: Manitoba Health and Healthy Living; 2008
12. Statistics Canada. Vital Statistics Death Database [online]. Available at: http://www.statcan.gc.ca/cgi-bin/imdb/p2SV.pl? Function5getSurvey&SDDS53233&lang5en&db5im db&adm58&dis52. Accessed March 6, 2011
13. Marrie RA, Yu N, Blanchard JF, Leung S, Elliott L. The rising prevalence and changing age distribution of multiple sclerosis in Manitoba. Neurology 2010; 74: 465-471
14. Marrie RA, Horwitz RI, Cutter G, Tyry T, Campagnolo D, Vollmer T.comorbidity delays diagnosis and increases disability at diagnosis in MS. Neurology 2009; 72: 117-124
15. Dallmeijer AJ, Beckerman H, de Groot V, van de Port IGL, Lankhorst GJ, Dekker J. Long-Term effect of comorbidity on the course of physical functioning in patients after stroke and with multiple sclerosis. J Rehabil Med 2009; 41: 322-326
16. Warren SA, Turpin KV, Pohar SL, Jones CA, Warren KG.comorbidity and health-related quality of life in people with multiple sclerosis. Int J MS Care 2009; 11: 6-16
17. Marrie RA, Yu B, Leung S, et al. Rising prevalence of vascular comorbidities in MS: validation of administrative definitions for diabetes, hypertension, hyperlipidemia. Mult Scler 2012; 18: 1310-1319
18. Marrie RA, Yu BN, Leung S, et al. The utility of administrative data for surveillance of comorbidity in multiple sclerosis: a validation study. Neuroepidemiology 2013; 40: 85-92
19. Marrie RA, Fisk JD, Yu BN, et al. Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance. BMC Neurol 2013; 13: 16
20. Marrie RA, Yu BN, Leung S, et al. Prevalence and incidence of ischemic heart disease in multiple sclerosis: a population-based validation study. Mult Scler Relat Disord 2013; 2: 355-361
21. Marrie RA, Yu BN, Leung S, et al. The incidence and prevalence of fibromyalgia are higher in multiple sclerosis than the general population: a population-based study. Mult Scler Relat Disord 2012; 1: 162-167
22. Lamarca R, Alonso J, Gómez G, Muñoz A. Left-Truncated data with age as time scale: an alternative for survival analysis in the elderly population. J Gerontol A Biol Sci Med Sci 1998; 53: M337-M343
23. Gross S, Lai T. Nonparametric estimation and regression analysis with left-Truncated and right-censored data. J Am Stat Assoc 1996; 91: 1166-1180
24. Allison PD. Survival Analysis Using SAS: A Practical Guide. Cary, NC: SAS Press; 1995
25. Rothman KJ, Greenland S, editors. Modern Epidemiology, 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 1998
26. Sjölander A, Greenland S. Ignoring the matching variables in cohort studies: when is it valid and why? Stat Med 2013; 32: 4696-4708
27. Ford HL, Gerry E, Johnson M, Williams R A prospective study of the incidence, prevalence and mortality of multiple sclerosis in Leeds. J Neurol 2002; 249: 260-265
28. Patzold U, Pocklington PR. Course of multiple sclerosis: first results of a prospective study carried out of 102 MS patients from 1976-1980. Acta Neurol Scand 1982; 65: 248-266
29. Ang DC, Choi H, Kroenke K, Wolfe F.comorbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis. J Rheumatol 2005; 32: 1013-1019
30. van Dooren FE, Nefs G, Schram MT, Verhey FR, Denollet J, Pouwer F. Depression and risk of mortality in people with diabetes mellitus: a systematic review and meta-Analysis. PLoS One 2013; 8: e57058
31. Mykletun A, Bjerkeset O, Dewey M, Prince M, Overland S, Stewart R. Anxiety, depression, and causespecific mortality: the HUNT Study. Psychosom Med 2007; 69: 323-331
32. Roness A, Mykletun A, Dahl AA. Help-seeking behaviour in patients with anxiety disorder and depression. Acta Psychiatr Scand 2005; 111: 51-58
33. Marrie RA, Elliott L, Marriott J, Cossoy M, Tennakoon A, Yu N.comorbidity increases the risk of hospitalizations in multiple sclerosis. Neurology 2015; 84: 350-358
34. Higashi T, Wenger NS, Adams JL, et al. Relationship between number of medical conditions and quality of care. N Engl J Med 2007; 356: 2496-2504
35. Larsen JP, Kvale G, Aarli JA. Multiple sclerosis and mortality statistics. Acta Neurol Scand 1985; 71: 237-241
36. O'Malley F, Dean G, Elian M. Multiple sclerosis and motor neurone disease: survival and how certified after death. J Epidemiol Community Health 1987; 41: 14-17
37. Ragonese P, Salemi G, Aridon P, et al. Accuracy of death certificates for motor neuron disease and multiple sclerosis in the province of Palermo in southern Italy. Neuroepidemiology 2002; 21: 148-152
38. Riudavets MA, Colegial C, Rubio A, Fowler D, Pardo C, Troncoso JC. Causes of unexpected death in patients with multiple sclerosis: a forensic study of 50 cases. Am J Forensic Med Pathol 2005; 26: 244-249
39. Sadovnick AD, Eisen K, Ebers GC, Paty DW. Cause of death in patients attending multiple sclerosis clinics. Neurology 1991; 41: 1193-1196
40. Redelings MD, McCoy L, Sorvillo F. Multiple sclerosis mortality and patterns of comorbidity in the United States from 1990 to 2001. Neuroepidemiology 2006; 26: 102-107